Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Novo Nordisk and Eli Lilly have given positive supply updates, aiming to reassure investors that they can continue to capitalize
Read More
Biotechnology
Enphase CEO says solar industry poised to rebound on falling interest rates and rising utility costs
Enphase CEO Badri Kothandaraman has called a bottom in the first quarter and sees falling interest rates and rising utility
Read More
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Catalent is the main supplier of fill-finish work, which involves filling and packaging syringes and injection pens, for Novo Nordisk's
Read More
This little-known genome editing stock is poised to surge more than 60%, JPMorgan says
According to analyst Eric Joseph, Beam is at the frontier of a rising theme for investors this year: therapeutics. Source
Read More
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
The CEOs of Merck, Johnson & Johnson and Bristol Myers Squibb will testify at the hearing on drug prices, Sen.
Read More
Humana stock plunges on dismal 2024 forecast, as insurers face soaring medical costs
The medical cost increases reflect an increasing number of older adults returning to hospitals to undergo procedures they had delayed
Read More
Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million
The settlement does not resolve the tens of thousands of lawsuits alleging that J&J's talc-based products caused cancer. Source link
Read More
Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump
The results come six months after J&J completed its spinoff of consumer health unit Kenvue, the company's biggest shake-up in
Read More
Gilead stock falls after lung cancer study results disappoint
Gilead will discuss the results with regulators and identify whether certain lung cancer patients may still benefit from the drug,
Read More